A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

Journal of Clinical Investigation

Volumn 122, Issue 8, 2012, Pages 2983-2988

  Lee, Ryan S ^a,b   Stewart, Chip ^c   Carter, Scott L ^c   Ambrogio, Lauren ^c   Cibulskis, Kristian ^c   Sougnez, Carrie ^c   Lawrence, Michael S ^c   Auclair, Daniel ^c   Mora, Jaume ^d   Golub, Todd R ^a,b,c,e   Biegel, Jaclyn A ^f,g   Getz, Gad ^c   Roberts, Charles W M ^a,b,h  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HOSPITAL SANT JOAN DE DÉU   (Spain)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SWI; TRANSCRIPTION FACTOR SNF;

ALLELE; ARTICLE; CHILDHOOD CANCER; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA SEQUENCE; EXOME; GENE; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PRIORITY JOURNAL; RHABDOID TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMARCB1 GENE; SOMATIC MUTATION;

CHILD, PRESCHOOL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; EXOME; FEMALE; HUMANS; INFANT; MALE; MUTATION; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RHABDOID TUMOR; TRANSCRIPTION FACTORS;

EID: 84864746573     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64400     Document Type: Article

References (25)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
2. TCGA. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
3. TCGA. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609-615.
4. Roberts CWM, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther. 2009;8(5):412-416.
5. McKenna ES, et al. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol. 2008;28(20):6223-6233.
6. Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56(1):7-15.
7. Versteege I, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394(6689):203-206. (Pubitemid 28325977)
8. Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11(7):481-492.
9. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.
10. Durinck S, et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 2011;1(2):137-143.
11. Stransky N, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157-1160.
12. Bozic I, et al. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A. 2010;107(43):18545-18550.
13. White FV, et al. Congenital disseminated malignant rhabdoid tumor: a distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11. Am J Surg Pathol. 1999;23(3):249-256. (Pubitemid 29117558)
14. Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci U S A. 2000;97(25):13796-13800.
15. Roberts CW, Leroux MM, Fleming MD, Orkin SH. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell. 2002;2(5):415-425. (Pubitemid 41039107)
16. Wang X, et al. TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest. 2011;121(10):3834-3845.
17. Jones S, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010;330(6001):228-231.
18. Wiegand KC, et al. ARID1A mutations in endometriosis- associated ovarian carcinomas. N Engl J Med. 2010;363(16):1532-1543.
19. Varela I, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature. 2011;469(7331):539-542.
20. Smida J, et al. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Clin Cancer Res. 2010;16(16):4256-4267.
21. Zhang J, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 2012;481(7381):329-334.
22. Ding L, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481(7382):506-510.
23. Carter SL, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotech. 2012;30(5):413-421.
24. Berger MF, et al. The genomic complexity of primary human prostate cancer. Nature. 2011;470(7333):214-220.
25. Chapman MA, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471(7339):467-472.